ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
3.090
+0.320 (11.55%)
At close: May 30, 2025, 4:00 PM
3.090
0.00 (0.00%)
After-hours: May 30, 2025, 7:00 PM EDT
ADC Therapeutics Market Cap
ADC Therapeutics has a market cap or net worth of $306.46 million as of May 30, 2025. Its market cap has decreased by -23.99% in one year.
Market Cap
306.46M
Enterprise Value
562.64M
1-Year Change
-23.99%
Ranking
Category
Stock Price
$3.09
Market Cap Chart
Since May 15, 2020, ADC Therapeutics's market cap has decreased from $2.04B to $306.46M, a decrease of -85.00%. That is a compound annual growth rate of -31.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2025 | 274.72M | 42.78% |
| Dec 31, 2024 | 192.41M | 43.49% |
| Dec 29, 2023 | 134.10M | -56.31% |
| Dec 30, 2022 | 306.95M | -80.20% |
| Dec 31, 2021 | 1.55B | -37.60% |
| Dec 31, 2020 | 2.48B | 21.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 662.23B |
| Johnson & Johnson | 373.45B |
| AbbVie | 328.75B |
| Novo Nordisk | 305.07B |
| UnitedHealth Group | 273.87B |
| Abbott Laboratories | 232.41B |
| AstraZeneca | 224.00B |
| Novartis AG | 223.92B |